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Abstract
Abstract
Objective — To use data from the Global Burden of Disease Study
between 1990 and 2017 to report the rates and trends of point
prevalence, annual incidence, and years lived with disability for neck
pain in the general population of 195 countries.
Design — Systematic analysis.
Data source — Global Burden of Diseases, Injuries, and Risk Factors
Study 2017.
Main outcome measures — Numbers and age standardised rates per
100 000 population of neck pain point prevalence, annual incidence,
and years lived with disability were compared across regions and
countries by age, sex, and sociodemographic index. Estimates were
reported with uncertainty intervals.
Results — Globally in 2017 the age standardised rates for point
prevalence of neck pain per 100 000 population was 3551.1 (95%
uncertainty interval 3139.5 to 3977.9), for incidence of neck pain per
100 000 population was 806.6 (713.7 to 912.5), and for years lived with
disability from neck pain per 100 000 population was 352.0 (245.6 to
493.3). These estimates did not change significantly between 1990 and
2017. The global point prevalence of neck pain in 2017 was higher in
females compared with males, although this was not significant at the
0.05 level. Prevalence increased with age up to 70-74 years and then
decreased. Norway (6151.2 (95% uncertainty interval 5382.3 to 6959.8)),
Finland (5750.3 (5058.4 to 6518.3)), and Denmark (5316 (4674 to
6030.1)) had the three highest age standardised point prevalence
estimates in 2017. The largest increases in age standardised point
prevalence estimates from 1990 to 2017 were in the United Kingdom
(14.6% (10.6% to 18.8%)), Sweden (10.4% (6.0% to 15.4%)), and Kuwait
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(2.6% (2.0% to 3.2%)). In general, positive associations, but with
fluctuations, were found between age standardised years lived with
disability for neck pain and sociodemographic index at the global level
and for all Global Burden of Disease regions, suggesting the burden is
higher at higher sociodemographic indices.
Conclusions — Neck pain is a serious public health problem in the
general population, with the highest burden in Norway, Finland, and
Denmark. Increasing population awareness about risk factors and
preventive strategies for neck pain is warranted to reduce the future
burden of this condition.
Introduction
Neck pain is a highly prevalent condition that leads to
considerable pain, disability, and economic cost.1 It not only
constitutes a major personal burden but also affects families
and the health system and economic structure of countries.2 3
Despite the impact of neck pain, its global burden has not been
comprehensively presented, in a way that can serve as the basis
for different types of epidemiological studies and for evaluating
diverse healthcare systems worldwide. For example, only one
study has reported the specific burden of neck pain at global
and regional level, using data from the Global Burden of Disease
Study 2010.4 More recently, a few studies have reported the
combined burden of musculoskeletal conditions at global or
regional level but have not provided specific data on neck pain.5 6
Moreover, national estimates on the burden from neck pain have
not been reported for all countries despite systematic reviews
having reported prevalence for a few specific countries.7 8 A
comprehensive analysis can also guide healthcare providers and
policymakers in identifying successful strategies used in regions
where the burden has been shown to decrease over time; and
apply them in regions with a higher burden. We report the
global, regional, and national level prevalence, incidence, and
years lived with disability from neck pain in the general
population in terms of numbers and age standardised rates for
195 countries from 1990 to 2017 by age, sex, and




Global Burden of Disease Study is a resource that measures
epidemiological levels and trends comprehensively and
comparably across the world. In the Global Burden of Diseases,
Injuries, and Risk Factors Study 2017, about 354 diseases and
injuries, 282 causes of death, and 84 risk factors were
systematically studied for 195 countries, 7 super regions, and
21 regions during 1990-2017.9 The 7 super regions are high
income (Asia Pacific and North America); Latin America and
the Caribbean; sub-Saharan Africa; North Africa and the Middle
East; South East Asia, east Asia, and Oceania; south Asia; and
central Europe, eastern Europe, and central Asia. The general
methodology of Global Burden of Disease 2017 is presented
elsewhere.9-12 See https://vizhub.healthdata.org/gbd-compare/
and http://ghdx.healthdata.org/gbd-results-tool for detailed
information on publicly available non-fatal estimates of Global
Burden of Disease 2017.
The Global Burden of Disease Study adheres to the guidelines
for accurate and transparent health estimates reporting
(GATHER) statement.13 As the Institute for Health Metrics and
Evaluation (IHME), the institute responsible for administering
the Global Burden of Disease, uses deidentified and aggregated
data only, informed consent is not applicable to the Global
Burden of Disease Study.
Case definition and data sources
In the current study, Global Burden of Disease Study defined
neck pain as pain in the cervical spine region (with or without
pain referred to the arms) that lasts for at least 24 hours. The
anatomical region of the neck was defined based on the
recommendation by the Bone and Joint Decade 2000-2010 Task
Force on Neck Pain and its Associated Disorders.14 Global
Burden of Disease Study considered pain in the neck or shoulder
as a proxy for neck pain.9
Ovid Medline, Embase, CINAHL, CAB abstracts, WHOLIS,
and SIGLE databases were searched for the Global Burden of
Disease Study 2010, and additionally PubMed was searched to
end of October 2017 for the Global Burden of Disease 2017.
IHME performed the searches. No age, sex, or language
restrictions were applied. The terms “neck pain”, “neck ache”,
“neckache”, and “cervical pain” were searched individually and
combined with each of the following terms: “prevalen*”,
“inciden*”, “cross-sectional”, “cross sectional”, “epidemiol*”,
“survey”, “population-based”, “population based”, “population
study”, and “population sample”.9 IHME used the following as
exclusion criteria: subpopulations clearly not representative of
the national population, not a population based study, low
sample size (<150), and review rather than original studies.9
Moreover, for the current analyses a second systematic review
was performed by IHME, searching for published studies on
neck pain from 2016 to 2017. In this additional search, a total
of 211 studies were identified and 30 studies retrieved after
screening of the title and abstract. After a full text review, four
studies were included in the current analyses.9 Additional
information was derived from unit record data of surveys in the
Global Burden of Disease’s repository of population health data,
including the National Health and Nutrition Examination Survey
(NHANES) and National Health Interview Survey (NHIS) in
the USA.9 In addition, Global Burden of Disease Study included
data from US claims data for 2000 and 2010-14 by state, as well
as Taiwan claims data for 2016.9 Global Burden of Disease
Study then estimated the prevalence of neck pain based on 388
site years, where a site year was defined as a country or other
subnational geographical unit contributing data in a given year.
Only 23 out of 195 countries representing 11 out of 21 Global
Burden of Disease regions provided data for estimating the
prevalence of neck pain.9 The Global Burden of Disease 2017
data input sources tool (http://ghdx.healthdata.org/gbd-2017/
data-input-sources) shows the data sources used for estimating
the burden of neck pain in different countries.
Data processing and disease model
Global Burden of Disease Study used a bayesian metaregression
tool, DisMod-MR, to pool heterogeneous data (eg, age groups).
The tool, used by IHME, produces a full set of age, sex, region,
and year specific estimates.15 Our disease model using
DisMod-MR included setting excess mortality to 0, and assumed
no incident or prevalent neck pain before age 5 years. Study
covariates were used for studies that reported broader anatomical
region, episode duration greater than three months, recall periods
of one week to one month, recall periods between two months
and one year, activity limiting neck pain, and studies conducted
among schoolchildren.9
With the exception of broad anatomical region, activity limiting
neck pain, and studies among schoolchildren populations, in
which coefficients were consistent with their reasonable ranges,
Global Burden of Disease Study calculated means and the upper
and lower uncertainty interval bounds for all other covariates
by crosswalking (ie, data comparing and merging) with
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NHANES data as baseline. The prior values for those
coefficients are reported elsewhere.9
Severity and years lived with disability
Supplementary table S1 shows the lay descriptions and disability
weights for neck pain severity levels, where disability weight
is defined as a weight factor that reflects the severity of the
disease or condition on a scale from 0 (perfect health) to 1
(equivalent to death).
The severity distributions are derived from the Medical
Expenditure Panel Surveys (MEPS) analysis conducted in the
USA (http://www.meps.ahrq.gov/survey_comp/hc_data_
collection.jsp). MEPS is a panel survey of the American
community dwelling population used to collect information on
the use and cost of healthcare. A panel lasts for two years, is
conducted in five rounds, and typically contains 30 000 to 35
000 respondents.9
MEPS data from 2000 to 2014 were used for the Global Burden
of Disease Study 2016, and respondents self-administered the
SF-12 twice for each panel, at rounds 2 and 4, typically about
a year apart. Only adults aged 18 years and older complete the
SF-12. MEPS also collects information on diagnoses based on
self-report of reasons for healthcare encounters. Although
diagnoses can also be derived from additional questions on
“problems that bother you” or conditions that led to “disability
days,” information on neck pain was mostly derived from data
on healthcare encounters.9 Professional coders translate the
verbatim text into three digit ICD (international classification
of diseases, ninth and 10th revisions) codes. The codes for neck
pain are 723.1 (ICD-9) and M54.2 (ICD-10).
To derive SF-12 values comparable with those used by the
Global Burden of Disease disability weights, small studies on
convenience samples were conducted, asking respondents to
fill in SF-12 to reflect 62 lay descriptions of different levels of
severity.15 16 From these responses, a relation between the SF-12
summary score and the Global Burden of Disease disability
weights was derived. Using regression modelling, average
disability weights were calculated while controlling for any
comorbidity by adding dummy variables for each comorbid
condition. As the case definition was point prevalence of neck
pain, Global Burden of Disease Study disregarded the proportion
of MEPS respondents with an existing neck pain diagnosis if
no disability attributable to neck pain was found. For the
remaining cases, the disability weight attributed to neck pain
was binned across the four health states, and thresholds were
assumed at the midpoint values.9
Compilation of results
Disability adjusted life year (DALY) is the standard metric used
to quantify burden11 and is calculated by combining years of
life lost due to premature mortality and years lived with
disability. One DALY can be considered as one lost year of
“healthy” life. As no evidence for mortality from neck pain was
found in the Global Burden of Disease Study, years lived with
disability and DALY estimates were the same.9 Global Burden
of Disease Study multiplied the average disability weight by
the age, sex, and region specific prevalence to derive years lived
with disability, and uncertainty was incorporated by sampling
1000 draws at each computational step. Uncertainty was
combined from multiple sources (eg, input data, corrections of
measurement error, and estimates of residual non-sampling
error). Uncertainty intervals were defined as the 25th and 975th
values of the ordered draws.
We also used smoothing splines models to determine the shape
of the association between neck pain burden in terms of years
lived with disability and sociodemographic index for 21 regions
and 195 countries.17 The sociodemographic index is a composite
indicator and includes lag distributed income per capita and
gross domestic product per capita smoothed over the preceding
10 years, average years of schooling for the population older
than 15 years, and total fertility rate under age 25 years. The
index ranges from 0 (less developed) to 1 (most developed). R
software version 3.5.2 was used to map the age standardised
point prevalence, the annual incidence, and rates of years lived
with disability.
Patient and public involvement
No patients were involved in setting the research question or
the outcome measures, nor were they involved in the design
and implementation of the study.
Results
Global level
Globally, the number of prevalent cases of neck pain was 288.7
million (95% uncertainty interval 254.7 to 323.5 million) in
2017, with an age standardised point prevalence per 100 000
population of 3551.1 (95% uncertainty interval 3139.5 to
3977.9), which did not change significantly from 1990 (−0.9%,
95% uncertainty interval −2.1% to 0.4% per 100 000
population). Moreover, neck pain accounted for 65.3 million
(95% uncertainty interval 57.7 to 73.9 million) incident cases,
with an age standardised rate per 100 000 population of 806.6
(95% uncertainty interval 713.7 to 912.5), which also did not
change significantly from 1990 (−0.7%, 95% uncertainty interval
−1.8% to 0.4% per 100 000 population) (table 1). The number
of years lived with disability due to neck pain in 2017 at the
global level was 28.6 million (95% uncertainty interval 20.0 to
40.2 million), with an age standardised rate per 100 000
population of 352 (95% uncertainty interval 245.6 to 493.3)
years lived with disability, and this was also unchanged from
1990 to 2017 (−0.7%, 95% uncertainty interval −2.0% to 0.6%
per 100 000 population) (table 1).
Regional level
The highest age standardised point prevalences of neck pain per
100 000 population in 2017 were in western Europe (4636.1
(95% uncertainty interval 4077.2 to 5250.5)), east Asia (4589.7
(4042.7 to 5168.9)), and North Africa and the Middle East
(4458.4 (3917.7 to 5022.4)). The lowest age standardised rates
per 100 000 population were in tropical Latin America (2505.6
(2194.4 to 2842.9)), eastern sub-Saharan Africa (2511.6 (2204.8
to 2846.1)), and Andean Latin America (2511.6 (2212.7 to
2832.5)) (table 1).
The highest age standardised annual incidences of neck pain
per 100 000 population were in east Asia (1029.0 (95%
uncertainty interval 910.5 to 1166.1)), North Africa and the
Middle East (975.6 (864.6 to 1109.0)), and high income North
America (906.4 (812.5 to 1012.5)). These rates were lowest for
Andean Latin America (624.0 (550.3 to 708.3)), the Caribbean
(624.4 (550.6 to 708.6)), and Australasia (624.5 (552.4 to 710.8))
(table 1).
East Asia (461.0 (320.1 to 643.9)), western Europe (461.0 (321.7
to 639.1)), and North Africa and the Middle East (437.4 (305.3
to 611.3)) also had the highest age standardised rate for years
lived with disability from neck pain per 100 000 population in
2017; whereas eastern sub-Saharan Africa (247.5 (171.9 to
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347.1)), tropical Latin America (248.3 (172.2 to 349.3)), and
the Caribbean (250.2 (172.5 to 354.5)) had the lowest age
standardised rates for years lived with disability per 100 000
population (table 1). Supplementary figures S1 and S2 show
the age standardised point prevalence and annual incidence of
neck pain per 100 000 population for all Global Burden of
Disease regions in 2017 for males and females, respectively.
Generally, the age standardised point prevalence, annual
incidence, and rates of years lived with disability from neck
pain have not changed over the past three decades. A statistically
significant increase in the age standardised point prevalence of
neck pain per 100 000 population was found in western Europe
(2.0% (95% uncertainty interval 1.2% to 2.7%)), southern
sub-Saharan Africa (0.3% (0.1% to 0.4%)), and eastern
sub-Saharan Africa (0.1% (0.0% to 0.2%)) between 1990 and
2017 (table 1). The highest percentage change in the age
standardised annual incidence of neck pain per 100 000
population from 1990 to 2017 was in western Europe (1.5%
(1.0% to 2.2%)), southern sub-Saharan Africa (0.2% (0.0% to
0.3%)), and eastern sub-Saharan Africa (0.1% (0.0% to 0.2%))
(table 1). In addition, the highest increase in age standardised
years lived with disability from neck pain per 100 000
population during 1990 to 2017 was in western sub‐Saharan
Africa (2.6% (0.3% to 5.2%)), western Europe (2% (1.1% to
3.0%)), and eastern sub‐Saharan Africa (0.9% (0.2% to 1.6%
(table 1). Supplementary figures S3 and S4 show the sex specific
percentage in age standardised point prevalence and annual
incidence of neck pain during 1990 to 2017, respectively.
The number of prevalent cases of neck pain increased from
164.3 million (95% uncertainty interval 144.9 to 185.9 million)
in 1990 to 288.7 million (254.7 to 323.5 million) in 2017. The
highest number of prevalent cases in 2017 were in East Asia,
south Asia, and western Europe (supplementary fig S5,
supplementary table S2).
Likewise, the number of incident cases of neck pain increased
substantially, from 38.2 million (33.7 to 43.5 million) in 1990
to 65.3 million (57.7 to 73.9 million) in 2017. The highest
numbers of incident cases of neck pain in 2017 were in east
Asia, south Asia, and North Africa and the Middle East
(supplementary fig S6, supplementary table S3).
National level
The national age standardised point prevalence of neck pain in
2017 ranged from 2443.9 to 6151.2 cases per 100 000
population. The countries with the highest age standardised
point prevalence estimates per 100 000 population in 2017 were
Norway (6151.2 (5382.3 to 6959.8)), Finland (5750.3 (5058.4
to 6518.3)), and Denmark (5316 (4674 to 6030.1)), whereas
Djibouti (2443.9 (2146.4 to 2771.9)), South Sudan (2449.8
(2149.8 to 2781.1)), and Burundi (2450.1 (2150 to 2778.9)) had
the lowest rates (fig 1 and supplementary table S2).
The national age standardised annual incidence of neck pain in
2017 varied from 599.6 in Canada to 1145 cases per 100 000
population in Norway. The highest rates were observed in
Norway (1145 (1008.8 to 1304.9)), Iran (1055.5 (927.8 to
1199.6)), and China (1037.7 (917.3 to 1176.9)), with the lowest
rates reported in Canada (599.6 (528.8 to 679.1)), Bhutan (612.4
(542.1 to 696.3)), and Pakistan (613.6 (543.4 to 698.3)) (fig 2
and supplementary table S3).
In addition, the national age standardised years lived with
disability from neck pain in 2017 ranged from 237.4 to 609.2
cases per 100 000 population. The highest rates were observed
in Norway (609.2 (425.5 to 849.8)), Finland (569.7 (389.3 to
797.1)), and Denmark (527.1 (369.2 to 740.6)) and the lowest
were observed in South Sudan (237.4 (165.1 to 332.4)),
Mozambique (241.1 (168.4 to 335.1)), and Eritrea (241.2 (168.1
to 338.7)) (supplementary fig S7 and table S4).
The percentage change in age standardised point prevalence
estimates per 100 000 population from 1990 to 2017 differed
substantially between countries, with the largest increases in
the UK (14.6% (10.6% to 18.8%)), Sweden (10.4% (6.0% to
15.4%)), and Kuwait (2.6% (2.0% to 3.2%)). In contrast, Taiwan
(−10.5% (−18.4% to −1.5%)), New Zealand (−7.4% (−11.2%
to −3.5%)), and Qatar (−2.6% (−3.0% to −2.1%)) showed the
largest decreases from 1990 to 2017 (supplementary table S2).
The largest increases in age standardised annual incidence of
neck pain per 100 000 population from 1990 to 2017 were in
the UK (9.1% (6.1% to 12.4%)), Sweden (6.5% (3.7% to 9.7%)),
and Kuwait (1.6% (1.1% to 2%)). In contrast, Taiwan (−8.2%
(−15.8% to −0.5%)), New Zealand (−6.0% (−9.7% to −2.3%)),
and Cape Verde (−1.5% (−2.0% to −0.9%)) showed the largest
decreases (supplementary table S3).
The change in age standardised years lived with disability from
neck pain per 100 000 population from 1990 to 2017 also varied
between countries. The UK (14.2% (10.2% to 18.5%)), Sweden
(10.3% (5.5% to 15.6%)), and Kuwait (2.7% (0.5% to 4.8%))
showed the largest increases in that period, whereas Taiwan
(−10.8% (−18.9% to −1.6%)), New Zealand (−7.4% (−11.6%
to −2.9%)), and the United Arab Emirates (−2.2% (−4.3% to
−0.1%)) showed the largest decreases (supplementary table S4).
Age and sex patterns
The global point prevalence of neck pain in 2017 was higher in
females and increased with age up to 70-74 years, then decreased
with older age. Similarly, the number of prevalent cases
increased with age and peaked at the 45-49 and 50-54 age groups
for males and females, respectively, then decreased with older
age (fig 3). In 2017, the global annual incidence of neck pain
was also found to be higher in females and generally increased
with age, peaking at the 65-69 age group. The number of
incident cases were highest at age 45-49 years, after which a
declining trend was observed at older ages (supplementary fig
S8). The pattern of years lived with disability by sex across age
groups was relatively similar to that of point prevalence estimate
(supplementary fig S9). Notably, no statistically significant
differences were found between males and females for
prevalence, incidence, and years lived with disability across the
age groups.
Observed burden of neck pain compared with
expected by sociodemographic index
Overall, a positive association was observed between the age
standardised years lived with disability from neck pain and
sociodemographic index at a global level as well as across
Global Burden of Disease regions. Namely, the burden of neck
pain is increased at higher levels of socioeconomic development
(fig 4).
Globally, the observed burden of neck pain was higher than
expected on the basis of sociodemographic development (as
measured by the sociodemogaphic index) over the past 28 years.
At the regional level, the observed burden was higher than
expected given the sociodemographic index for east Asia,
western Europe, North Africa and the Middle East, high income
North America, and western sub-Saharan Africa, and mostly
lower than expected for the remaining Global Burden of Disease
regions (fig 4).
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High burden of neck pain was not, however, limited to
developed countries—Canada, Australia, and New Zealand had
much lower than expected burdens, whereas in developing
countries such as Afghanistan, Yemen, and Sudan, the burden
of neck pain was much higher than the expected level on the
basis of the sociodemographic index (fig 5).
Discussion
In this study, we report the prevalence, incidence, years lived
with disability, and age standardised rates for neck pain in the
general population for 195 countries, from 1990 to 2017. In
2017, there were 288.7 million prevalent cases, 65.3 million
incident cases, and 28.6 million years lived with disability.
Although the age standardised rates of point prevalence, annual
incidence, and years lived with disability from neck pain have
not changed significantly over the measurement period, the
number of prevalent cases, incident cases, and years lived with
disability has increased, possibly as a result of population growth
and aging—not specifically reported in previous studies.
Since the last Global Burden of Disease report using data from
20104 a small but statistically significant decrease in global age
standardised point prevalence estimate from 4.9% in 2010 to
3.5% has been observed. Moreover, the Global Burden of
Disease Study 20104 found that high income North American
and western Europe had the highest age standardised point
prevalence estimates. In contrast, our study found that in 2017
western Europe and east Asia had the global highest age
standardised point prevalence estimates. These differences can
be mainly attributable to the methodologies and data sources
used in the two studies. Unfortunately, most previous systematic
reviews7 8 18 19 provide results that are incomparable to ours, given
they used different definitions for neck pain and failed to include
global prevalence or incidence data.
In our study, age standardised point prevalence, annual
incidence, and years lived with disability in 2017 and percentage
changes since 1990, were provided for 195 countries, enabling
the burden of neck pain to be compared across different nations.
The results presented here were mainly derived from modelled
data through processes in the bayesian metaregression tool
DISMOD-MR 2.1, as only a few countries had actual national
data on prevalence and incidence of neck pain. Hence, national
level estimates should be interpreted with caution. Importing
data on neck pain in specific national health surveys, if available,
is therefore encouraged to ensure the capture of more
representative data for each country. In fact, this strategy not
only will strengthen future Global Burden of Disease studies
but could also be used to monitor county specific burden of
neck pain as well as the long term efficiency and effectiveness
of prevention and treatment strategies used to tackle it. We
acknowledge this approach would require resources that are not
always available in low to middle income countries, and that a
more globally coordinated effort might be required.
The point prevalence estimate of neck pain was found to be
higher in females across all age groups, confirming the findings
of previous studies.4 8 19 In addition, point prevalence estimates
in our study peaked at middle ages, which is also confirmed by
other studies.4 8 19 The highest burden was among men aged
45-49 years and women aged 45-54 years. This has direct
implications for clinical practice and policy, as preventive and
educational approaches targeting these specific groups should
be encouraged globally. Whereas neck pain has been a relatively
understudied condition, a strong evidence base exists for low
back pain. It is likely that the guidance for low back pain—to
keep imaging to a minimum and to provide advice and education
to remain active—can be extrapolated to neck pain, but this
remains to be determined.
The developing status of regions and countries is one of the
important factors of neck pain burden that has not been dealt
with in previous studies.4 7 19 At a regional level, generally a
positive association was found between regional level
sociodemographic index and age standardised years lived with
disability from neck pain between 1990 and 2017. This means
that the burden of neck pain is generally higher at higher
socioeconomic levels of development. This phenomenon could
possibly be driven by increased levels of physical inactivity,
obesity, and aging.
Detection and control of risk factors are common approaches
in prevention programmes. The risk factors for neck pain are
classified into different categories, such as demographic and
socioeconomic factors, previous health or past pain or
comorbidities, road traffic injuries or workplace factors,
psychological and social factors, genetics, and health
behaviours.19 Unfortunately, the attributable burden of neck pain
due to these risk factors has not yet been assessed in these Global
Burden of Disease estimates. Policymakers might also want to
consider country specific patterns of risk factors for neck pain
in their management recommendations.
Strengths and limitations of this study
Although using the US derived Medical Expenditure Panel
Surveys (MEPS) has allowed Global Burden of Disease to
estimate the severity distribution of neck pain while taking
morbidity into account, some limitations should be considered.
Recall bias is possible as data were collected at five follow-up
points over two years. Also, MEPS might not be representative
of the health state experience for neck pain across the globe. In
low to middle income countries, where prevention and
management strategies for neck pain might not be as efficient
as in high income countries, the health state experience could
be different.
Conclusions and policy implications
Neck pain is a public health issue in general populations gobally,
but varies considerably between countries. Improving health
data on all musculoskeletal conditions such as neck pain in all
countries and regions is strongly suggested for improving the
Global Burden of Disease estimates. Although the age
standardised point prevalence, annual incidence, and years lived
with disability from neck pain did not change between 1990
and 2017, its burden remains high, with middle aged men and
women particularly at risk. Increasing population awareness
about neck pain and its risk factors as well as the importance
of early detection and management is warranted to reduce the
future burden of this condition.
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What is already known on this topic
Neck pain varies widely between countries but is a highly prevalent
condition that leads to considerable pain, disability, and economic cost
The Global Burden of Disease Study 2010 highlighted the high global
burden of neck pain
What this study adds
In this study, the global age standardised point prevalence, annual
incidence, and years lived with disability from neck pain per 100 000
population in 2017 were estimated to be 3551, 807, and 352, respectively
Western Europe, east Asia and North Africa and the Middle East had the
highest age-standardised point prevalence of neck pain in 2017.
Norway, Finland, and Denmark had the highest age standardised point
prevalence estimates for neck pain in 2017, whereas the UK, Sweden,
and Kuwait showed the largest increases between 1990 and 2017
We thank the staff at the Institute for Health Metrics and Evaluation and its
collaborators who prepared these publicly available data and the support of the
Social Determinants of Health Research Center of Shahid Beheshti University of
Medical Sciences. This study is based on publicly available data and solely reflects
the opinion of its authors and not that of the Institute for Health Metrics and
Evaluation.
Contributors: SS, AAK, LM, and MLF designed the study. SS, AAK, MAM, AA-H,
and AA-A analysed the data and performed the statistical analyses. SS, AAK, DB,
ES, MS, MC, and MLF drafted the initial manuscript. All authors reviewed the
drafted manuscript for critical content and approved the final version. The
corresponding author attests that all listed authors meet authorship criteria and
that no others meeting the criteria have been omitted. SS and MLF are the
guarantors.
Funding: The Global Burden of Disease Study is funded by the Bill and Melinda
Gates Foundation. The funder was not involved in the preparation of this manuscript.
The present report was also supported by Shahid Beheshti University of Medical
Sciences, Tehran, Iran (grant No 20732-4-7). MLF holds a National Health and
Medical Research Council of Australia research fellowship.
Competing interests: All authors have completed the ICMJE uniform disclosure
form at www.icmje.org/coi_disclosure.pdf and declare: Global Burden of Disease
Study is funded by the Bill and Melinda Gates Foundation, and this study was
supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran (grant
No 20732-4-7); no financial relationships with any organisations that might have
an interest in the submitted work in the previous three years; no other relationships
or activities that could appear to have influenced the submitted work.
Ethical approval: This study was approved by ethics committee of Shahid Beheshti
University of Medical Sciences, Tehran, Iran (IR.SBMU.RETECH.REC.1398.446).
Data sharing: The data used for the analyses are publicly available from the Institute
of Health Metrics and Evaluation website (www.ihme.org).
The lead authors (SS and MLF are manuscript’s guarantors) affirms that the
manuscript is an honest, accurate, and transparent account of the study being
reported; that no important aspects of the study have been omitted; and any
discrepancies have been explained.
Dissemination to participants and related patient and public communities: Our
results will be disseminated through media outlets and presentations at scientific
conferences and academic events. Given that no patients were recruited for the
study, there are no plans to disseminate the results to study participants.
Publisher’s note: Published maps are provided without any warranty of any kind,
either express or implied. BMJ remains neutral with regard to jurisdictional claims
in published maps.
1 Henschke N, Kamper SJ, Maher CG. The epidemiology and economic consequences of
pain. Mayo Clin Proc 2015;90:139-47. 10.1016/j.mayocp.2014.09.010 25572198
2 Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JAAmerican Society of Interventional
Pain Physicians. Comprehensive review of epidemiology, scope, and impact of spinal
pain. Pain Physician 2009;12:E35-70.19668291
3 Haldeman S, Carroll L, Cassidy JD. Findings from the bone and joint decade 2000 to
2010 task force on neck pain and its associated disorders. J Occup Environ Med
2010;52:424-7. 10.1097/JOM.0b013e3181d44f3b 20357682
4 Hoy D, March L, Woolf A, etal . The global burden of neck pain: estimates from the global
burden of disease 2010 study. Ann Rheum Dis 2014;73:1309-15.
10.1136/annrheumdis-2013-204431 24482302
5 Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. The world-wide burden of
musculoskeletal diseases: a systematic analysis of the World Health Organization Burden
of Diseases Database. Ann Rheum Dis 2019;78:844-8.
10.1136/annrheumdis-2019-215142 30987966
6 Moradi-Lakeh M, Forouzanfar MH, Vollset SE, etal . Burden of musculoskeletal disorders
in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of
Disease Study 2013. Ann Rheum Dis 2017;76:1365-73.
10.1136/annrheumdis-2016-210146 28209629
7 Fejer R, Kyvik KO, Hartvigsen J. The prevalence of neck pain in the world population: a
systematic critical review of the literature. Eur Spine J 2006;15:834-48.
10.1007/s00586-004-0864-4 15999284
8 Hoy DG, Protani M, De R, Buchbinder R. The epidemiology of neck pain. Best Pract Res
Clin Rheumatol 2010;24:783-92. 10.1016/j.berh.2011.01.019 21665126
9 James SL, Abate D, Abate KH, etal. GBD 2017 Disease and Injury Incidence and
Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years
lived with disability for 354 diseases and injuries for 195 countries and territories,
1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet
2018;392:1789-858. 10.1016/S0140-6736(18)32279-7 30496104
10 Roth GA, Abate D, Abate KH, etal. GBD 2017 Causes of Death Collaborators. Global,
regional, and national age-sex-specific mortality for 282 causes of death in 195 countries
and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study
2017. Lancet 2018;392:1736-88. 10.1016/S0140-6736(18)32203-7 30496103
11 Kyu HH, Abate D, Abate KH, etal. GBD 2017 DALYs and HALE Collaborators. Global,
regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries
and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a
systematic analysis for the Global Burden of Disease Study 2017. Lancet
2018;392:1859-922. 10.1016/S0140-6736(18)32335-3 30415748
12 Stanaway JD, Afshin A, Gakidou E, etal. GBD 2017 Risk Factor Collaborators. Global,
regional, and national comparative risk assessment of 84 behavioural, environmental and
occupational, and metabolic risks or clusters of risks for 195 countries and territories,
1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet
2018;392:1923-94. 10.1016/S0140-6736(18)32225-6 30496105
13 Stevens GA, Alkema L, Black RE, etal. The GATHER Working Group). Guidelines for
Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet
2016;388:e19-23. 10.1016/S0140-6736(16)30388-9 27371184
14 Guzman J, Hurwitz EL, Carroll LJ, etal . A new conceptual model of neck pain: linking
onset, course, and care: the Bone and Joint Decade 2000-2010 Task Force on Neck Pain
and Its Associated Disorders. J Manipulative Physiol Ther 2009;32(Suppl):S17-28.
10.1016/j.jmpt.2008.11.007 19251062
15 Hoy DG, Smith E, Cross M, etal . The global burden of musculoskeletal conditions for
2010: an overview of methods. Ann Rheum Dis 2014;73:982-9.
10.1136/annrheumdis-2013-204344 24550172
16 Salomon JA, Vos T, Hogan DR, etal . Common values in assessing health outcomes from
disease and injury: disability weights measurement study for the Global Burden of Disease
Study 2010. Lancet 2012;380:2129-43. 10.1016/S0140-6736(12)61680-8 23245605
17 Wang Y. Smoothing splines: methods and applications. Chapman and Hall/CRC,
201110.1201/b10954.
18 Cohen SP. Epidemiology, diagnosis, and treatment of neck pain. Mayo Clin Proc
2015;90:284-99. 10.1016/j.mayocp.2014.09.008 25659245
19 Hogg-Johnson S, van der Velde G, Carroll LJ, etal. Bone and Joint Decade 2000-2010
Task Force on Neck Pain and Its Associated Disorders. The burden and determinants of
neck pain in the general population: results of the Bone and Joint Decade 2000-2010
Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976)
2008;33(Suppl):S39-51. 10.1097/BRS.0b013e31816454c8 18204398
Accepted: 25 02 2020
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No
commercial re-use. See rights and permissions. Published by
BMJ.http://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed
in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license,
which permits others to distribute, remix, adapt and build upon this work, for commercial
use, provided the original work is properly cited. See: http://creativecommons.org/licenses/
by/4.0/.
Open Access: Reuse allowed Subscribe: http://www.bmj.com/subscribe
BMJ 2020;368:m791 doi: 10.1136/bmj.m791 (Published 26 March 2020) Page 6 of 12
RESEARCH
 on 27 M










J: first published as 10.1136/bm
j.m






Table 1| Prevalence, incidence, and years lived with disability (YLDs) from neck pain in general population in 2017 for males and females,
and percentage change of age standardised rates (ASRs) per 100 000 population between 1990 and 2017 by Global Burden of Disease
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Fig 1 Age standardised point prevalence of neck pain per 100 000 population in 2017, by country. Generated from data
available at http://ghdx.healthdata.org/gbd-results-tool
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Fig 2 Age standardised annual incidence of neck pain per 100 000 population in 2017, by country. Generated from data
available at http://ghdx.healthdata.org/gbd-results-tool
Fig 3 Global number of prevalent cases and age standardised point prevalence of neck pain per 100 000 population by
age and sex, 2017. Dotted and dashed lines indicate 95% upper and lower uncertainty intervals, respectively.
Generated from data available at http://ghdx.healthdata.org/gbd-results-tool
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Fig 4 Age standardised years lived with disability (YLD) from neck pain per 100 000 population for 21 Global Burden of
Disease regions by sociodemographic index, 1990-2017. Black line represents expected values based on
sociodemographic index and disease rates in all locations. Twenty eight points are plotted for each Global Burden
of Disease region and show observed age standardised years lived with disability from 1990 to 2017 for that region.
Generated from data available at http://ghdx.healthdata.org/gbd-results-tool
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Fig 5 Age standardised years lived with disability (YLD) from neck pain per 100 000 population by 195 countries and
sociodemographic index, 2017. Black line represents expected values. Each point shows observed age standardised
years lived with disability for specified country in 2017. Generated from data available at
http://ghdx.healthdata.org/gbd-results-tool
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